If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 67   2006   NUMBER 1

Editorial

5 Focus on Childhood and Adolescent Mental Health. Melissa P. DelBello
[PDF]

Commentary

7 The Impact of Disasters and Their Aftermath on Mental Health. [CME] Robert J. Ursano, Frederick P. Cerise, Robert DeMartino, Dori B. Reissman, and M. Katherine Shear
[PDF]

Original Articles

15 High-Dose Sertraline Strategy for Nonresponders to Acute Treatment for Obsessive-Compulsive Disorder: A Multicenter Double-Blind Trial. Philip T. Ninan, Lorrin M. Koran, Ari Kiev, Jonathan R. T. Davidson, Steven A. Rasmussen, John M. Zajecka, Delbert G. Robinson, Paul Crits-Christoph, Francine S. Mandel, and Carol Austin
[Abstract] [PDF]

23 Prevalence and Severity of Intimate Partner Violence and Associations With Family Functioning and Alcohol Abuse in Psychiatric Inpatients With Suicidal Intent. [CME] Alison M. Heru, Gregory L. Stuart, Samara Rainey, Jody Eyre, and Patricia Ryan Recupero
[Abstract] [PDF]

30 Botulinum Toxin Treatment of Social Anxiety Disorder With Hyperhidrosis: A Placebo-Controlled Double-Blind Trial. Kathryn M. Connor, Jonathan L. Cook, and Jonathan R. T. Davidson
[Abstract] [PDF]

37 Validity of the Impact Factor of Journals as a Measure of Randomized Controlled Trial Quality. Corrado Barbui, Andrea Cipriani, Lara Malvini, and Michele Tansella
[Abstract] [PDF]

41 Remission of Generalized Anxiety Disorder: A Review of the Paroxetine Clinical Trials Database. Karl Rickels, Moira Rynn, Malini Iyengar, and David Duff
[Abstract] [PDF]

48 Are Antidepressants Associated With New-Onset Suicidality in Bipolar Disorder? A Prospective Study of Participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Mark S. Bauer, Stephen R. Wisniewski, Lauren B. Marangell, Cheryl A. Chessick, Michael H. Allen, Ellen B. Dennehy, David J. Miklowitz, Michael E. Thase, and Gary S. Sachs, for the STEP-BD Investigators
[Abstract] [PDF]

56 Nativity and DSM-IV Psychiatric Disorders Among Puerto Ricans, Cuban Americans, and Non-Latino Whites in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. Margarita Alegria, Glorisa Canino, Frederick S. Stinson, and Bridget F. Grant
[Abstract] [PDF]

66 Open-Label Tiagabine Monotherapy for Major Depressive Disorder With Anxiety. Linda L. Carpenter, Jordan M. Schecter, Audrey R. Tyrka, Andrea F. Mello, Marcelo F. Mello, Ryan Haggarty, and Lawrence H. Price
[Abstract] [PDF]

72 Venlafaxine Extended Release in the Short-Term Treatment of Depressed and Anxious Primary Care Patients With Multisomatoform Disorder. Kurt Kroenke, Nicholas Messina III, Isma Benattia, Jay Graepel, and Jeff Musgnung
[Abstract] [PDF]

81 An Open Trial of Adjunctive Escitalopram in Bipolar Depression. Manoela Fonseca, Jair C. Soares, John P. Hatch, Aida P. Santin, and Flavio Kapczinski
[Abstract] [PDF]

87 Psychiatric Phenotype of the Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) in Males: Newly Described Fronto-Subcortical Dementia. Susan Bacalman, Faraz Farzin, James A. Bourgeois, Jennifer Cogswell, Beth L. Goodlin-Jones, Louise W. Gane, Jim Grigsby, Maureen A. Leehey, Flora Tassone, and Randi J. Hagerman
[Abstract] [PDF]

95 Differential Efficacy of Olanzapine and Lithium in Preventing Manic or Mixed Recurrence in Patients With Bipolar I Disorder Based on Number of Previous Manic or Mixed Episodes. Terence A. Ketter, John P. Houston, David H. Adams, Richard C. Risser, Adam L. Meyers, Douglas J. Williamson, and Mauricio Tohen
[Abstract] [PDF]

102 The Association Between Moderate Alcohol Use and Illness Severity in Bipolar Disorder: A Preliminary Report. Benjamin I. Goldstein, Vytas P. Velyvis, and Sagar V. Parikh
[Abstract] [PDF]

107 Comparison of Treatment-Emergent Extrapyramidal Symptoms in Patients With Bipolar Mania or Schizophrenia During Olanzapine Clinical Trials. Patrizia A. Cavazzoni, Paul H. Berg, Ludmila A. Kryzhanovskaya, Susan D. Briggs, Tamra E. Roddy, Mauricio Tohen, and John M. Kane
[Abstract] [PDF]

Focus on Childhood and Adolescent Mental Health

114 The Past, Future, and Present of Childhood and Adolescent Mental Health. Melissa P. DelBello
[PDF]

115 The Health Care Crisis of Childhood-Onset Bipolar Illness: Some Recommendations for Its Amelioration. Robert M. Post and Robert A. Kowatch
[Abstract] [PDF]

126 Children of Currently Depressed Mothers: A STAR*D Ancillary Study. Daniel J. Pilowsky, Priya J. Wickramaratne, A. John Rush, Carroll W. Hughes, Judy Garber, Erin Malloy, Cheryl A. King, Gabrielle Cerda, A. Bela Sood, Jonathan E. Alpert, Stephen R. Wisniewski, Madhukar H. Trivedi, Ardesheer Talati, Marlene M. Carlson, Harry Hong Liu, Maurizio Fava, and Myrna M. Weissman
[Abstract] [PDF]

137 Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study Followed by Abrupt Discontinuation. James M. Swanson, Laurence L. Greenhill, Frank A. Lopez, Andrew Sedillo, Craig Q. Earl, John G. Jiang, and Joseph Biederman
[Abstract] [PDF]

Academic Highlights

148 New Developments in the Treatment of ADHD. [CME]
[PDF]

ASCP CORNER

160 Real-Life Switching Strategies With Second-Generation Antipsychotics. Christoph U. Correll
[PDF]

Letters To the Editor

162 Methodological Issues in a Comparative Study of Ziprasidone and Risperidone. Georges M. Gharabawi, Cynthia A. Bossie, Ramy Mahmoud, Carla M. Canuso, Robert A. Lasser, Ibrahim Turkoz, and Andrew Greenspan
[PDF]

Reply by Donald E. N. Addington, Christos Pantelis, Antony D. Loebel, and Steven J. Romano
[PDF]

164 Methodological Concerns Regarding the Relation Between Mefloquine and Serious Psychiatric Events in Females. Martin L. Tepper and Barbara A. Strauss
[PDF]

  • Reply by Bruno H.Ch. Stricker

165 Propofol for Severe, Refractory Mania: A Case Report. Jeffrey S. Cluver and Susan J. Hardesty
[PDF]

166 Galantamine-Induced QTc Prolongation. Matthew W. Nelson and Robert W. Buchanan
[PDF]

Book Reviews 168